Axim Biotechnologies annual free cash flow
2012
2014
2015
2016
2020
2021
2022
2023
2024
Axim Biotechnologies Free Cash Flow (FCF) History (AXIM)
Axim Biotechnologies reported −$857,897 in free cash flow for fiscal 2024, an increase of $172,603 from the previous fiscal year, with a free cash flow margin of −1217.60%.
View full Axim Biotechnologies company overviewAxim Biotechnologies free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$857,897 | $172,603 | — | −1217.60% |
| 2023 | 2023-12-31 | −$1.0M | $1.0M | — | −2607.67% |
| 2022 | 2022-12-31 | −$2.1M | $474,224 | — | −23132.80% |
| 2021 | 2021-12-31 | −$2.5M | $785,763 | — | −4180.05% |
| 2020 | 2020-12-31 | −$3.3M | — | — | — |
| 2016 | 2016-12-31 | −$1.3M | $261,818 | — | −2750.04% |
| 2015 | 2015-12-31 | −$1.6M | −$1.2M | — | −3166.44% |
| 2014 | 2014-12-31 | −$338,999 | — | — | — |
| 2012 | 2012-12-31 | −$78,895 | — | — | −182.07% |
Axim Biotechnologies quarterly free cash flow
Q3.12
Q3.22
Q1.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | −$255,345 | — | — | −481.97% |
| Q3 2022 | 2022-09-30 | −$323,935 | — | — | −24652.59% |
| Q3 2012 | 2012-09-30 | $5,900 | — | — | +54.46% |
Axim Biotechnologies free cash flow growth trends
Axim Biotechnologies's latest reported quarter, Q1 2024, generated −$255,345 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Axim Biotechnologies source filings ↗